Management of localized-stage follicular lymphoma: Changing the paradigm?

Journal of Clinical Oncology

Volumn 30, Issue 27, 2012, Pages 3328-3329

  Montoto, Silvia ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RITUXIMAB;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL DECISION MAKING; EDITORIAL; FOLLICULAR LYMPHOMA; FOLLOW UP; HUMAN; INVOLVED FIELD RADIOTHERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

HUMANS; LYMPHOMA, FOLLICULAR;

EID: 84866760863     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.43.5768     Document Type: Editorial

References (7)

1. Fisher RI, LeBlanc M, Press OW, et al: New treatment options have changed the survival of patients with follicular lymphoma. J Clin Oncol 23:8447-8452, 2005
2. Swenson WT, Wooldridge JE, Lynch CF, et al: Improved survival of follicular lymphoma patients in the United States. J Clin Oncol 23:5019-5026, 2005 (Pubitemid 46224008)
3. Liu Q, Fayad L, Cabanillas F, et al: Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center. J Clin Oncol 24:1582-1589, 2006 (Pubitemid 46638782)
4. Friedberg JW, Byrtek M, Link BK, et al: Effectiveness of first-line management strategies for stage I follicular lymphoma: Analysis of the National LymphoCare study. J Clin Oncol 30:3368-3375, 2012
5. National Comprehensive Cancer Network: NCCN clinical practice guidelines in oncology. http://www.nccn.org/professionals/physician-gls/pdf/nhl.pdf
6. Dreyling M, ESMO Guidelines Working Group: Newly diagnosed and relapsed follicular lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 21:v181-183, 2010 (suppl 5)
7. Trotman J, Fournier M, Lamy T, et al: Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants. J Clin Oncol 29:3194-3200, 2011